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Inbred mice developing autoimmune disease  have provided an important  model 
for the study of systemic lupus erythematosus (SLE) 1 (1-4).  Like patients with  this 
disease,  autoimmune  mice  demonstrate  antinuclear  antibodies,  immune  complex 
deposition,  and  glomerulonephritis.  Although  inherited  factors undoubtedly  play a 
major role in the etiology of these illnesses, a common genetic abnormality has not as 
yet been identified  among the now well-characterized strains.  In the study of these 
mice, disturbances have been observed in various aspects of B and T  cell maturation 
and function  (5-19), although the relationship of these abnormalities to the develop- 
ment of autoreactivity is unclear. These functional studies have been primarily based 
on  the  analysis  of the  response  to  ordinary  antigens  on  the  assumption  that  an 
immunoregulatory defect responsible for autoreactivity would have a counterpart in 
a normal immune response as well. The validity of this approach is dependent on the 
existence  of common  immunoregulatory mechanisms  for normal  and  autoimmune 
responses in these animals. One way to test this premise is to compare the production 
of different autoantibodies. It can be argued that, if autoantibody responses resulted 
from a  common  pathogenetic  mechanism,  they  should  demonstrate  similarities  in 
qualitative  and  quantitative  aspects  of antibody  production  such  as  time-course, 
magnitude, clonality, and maturation. 
MRL  substrain  mice  provide  a  unique  model  for  investigating  this  aspect  of 
autoimmunity  (3,  4,  20).  Both  MRL-lpr/lpr  and  MRL-+/+  mice develop immu- 
nological illnesses with features of SLE, although in the 1  pr/1 pr substrain the disease 
is greatly accelerated and is associated with the development of massive lymphopro- 
liferation. Unique among the murine models for SLE, both MRL substrains produce 
antibodies to the Sm antigen, a nuclear glyeoprotein (21,  22).  In human disease, anti- 
Sm antibodies  (anti-Sm) are considered highly specific for SLE (23-26).  In addition, 
it is known that the MRL-lpr/lpr  substrain mice produce high titered antibody to 
native DNA (anti-DNA), another marker for human SLE (27-29). 
In the studies presented here, the time-course and quantitative aspects of anti-Sm 
and anti-DNA antibody production have been assessed in both MRL substrain mice. 
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The  results  indicate that  the  two  responses  differ  significantly in  their  pattern  of 
expression and appear to be regulated by independent mechanisms. A  single immu- 
noregulatory  disturbance for  both  responses  cannot  account  for  the  quantitative 
aspects of autoantibody production presented here. 
Materials and Methods 
Mice.  Male MRL-+/+ and MRL-1 pr/1 pr mice were purchased from The Jackson Labo- 
ratory, Bar Harbor, Maine. Beginning  at the age of 8-12 w, mice were bled from the retroorbital 
plexus at regular intervals. After clotting, sera were separated and stored at -20°C until use. 
Passive Hemagglutination Assay of Anti-Sin Antibodies.  Anti-Sm antibodies were measured by 
the passive hemagglutination (PHA) method of Nakamura et al. (26) with modifications. The 
antigen source was a  soluble extract  of rabbit thymus powder  (Pel  Freeze Biologicals  Inc., 
Rogers,  Ark.)  in phosphate-buffered saline (PBS;  0.15M  NaCI, 0.01  M  phosphate, pH  7.4). 
This material, rabbit thymus extract (RTE), was used to coat sheep erythrocytes that had been 
tanned using a concentration  of 0.01% tannic acid. For the hemagglutination  assay, the starting 
dilution of all sera was 1:5 in a vol of 25 #1, and twofold dilutions were carried out to 22 wells. 
Hemagglutination patterns were determined at 2 and 24 h, and results reported in terms of the 
number  of twofold dilutions  of serum producing hemagglutination.  The specificity of antibodies 
detected as anti-Sm was established by hemagglutination testing using RTE cells treated with 
ribonuclease to remove ribonueleoprotein (RNP)  antigen whose  detection could confuse the 
interpretation of the results.  Such treated cells, however, gave results equivalent to RTE cells 
that had not been treated with RNase. In addition, for selected sera,  immunodiffusion  testing 
using known index sera from patients with SLE was used to establish the identity of antibodies 
as anti-Sm. 
Assay of Anti-DNA Antibodies.  Antibodies to native DNA were assayed by an enzyme-linked 
immunosorbent assay (ELISA) that has recently been developed.  2 A solid phase support for the 
assay was prepared by coating wells of a polystyrene microtiter plate with native salmon sperm 
DNA preparations (Sigma Chemical Co., St. Louis, Mo.) at a concentration of 1 pg/ml, and by 
washing to  remove  unbound DNA.  Individual wells  then  were  exposed  for  1 h  at  room 
temperature to a  1:100 dilution of serum in PBS that contained 0.05% Tween 20 (PBS-Tween). 
After additional washing with PBS-Tween buffer, a  1:500 dilution of peroxidase-coupled goat 
anti-mouse IgG (immunoglobulin  heavy and light chain specific; Litton Bionetics, Kensington, 
Md.) was added for 1 h. After additional washes,  the substrate ABTS (2,2'-Azino-di [3-ethyl- 
benzthiazoline-sulfonate]; Sigma Chemical Co.)  was added and incubated for 30 min. The 
contents of each well were then diluted with 0.75  mt of 0.1  M  citrate buffer, pH 4, and the 
optical density at 417 nm read immediately. All determinations were performed in duplicate. 
For each serum, the reaction with uncoated wells was also measured. Values are reported as the 
difference of the average of the colorimetric yield of wells coated with DNA and uncoated 
wells. Results presented have not been corrected for serum dilution and represent the actual 
measured differences in optical densities. Evidence that this reaction is specific for anti-native 
DNA is considered in detail elsewhere. 
Results 
Kinetics of the Anti-Sm  Response in MRL-lpr/ lpr and MRL-+ / +.  To ascertain the 
pattern of the specific autoantibody responses of individual animals, sequential bleeds 
from a  large number of MRL  mice of both substrains were tested  for anti-Sm and 
anti-DNA antibodies. MRL-lpr/lpr  mice were followed until at  least 6  mo of age, 
when significant mortality among the  study  group  had  already occurred,  whereas 
MRL-+/+  mice were followed until at least the age of 8 mo. 
A  total of 23  Ipr/lpr and 16 +/+  mice were studied and sequential sera analyzed 
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for the production of anti-Sm antibody. All but two of the  l pr/lpr animals produced 
anti-Sm in at least one bleeding. In contrast, 10/16 +/+  animals showed demonstrable 
anti-Sm production on at least one occasion. The kinetics of the responses in individual 
animals showed marked variation among individual animals as demonstrated in Figs. 
1 and 2, which illustrate the anti-Sm and anti-DNA responses of representative MRL 
animals. 
Comparison  of  the  peak  anti-Sm  antibodies  of  both  substrains  (Fig.  3)  also 
demonstrated large variation in the level of responsiveness; several animals failed to 
demonstrate detectable anti-Sm antibody, and responders showed a broad distribution 
in  the peak antibody levels. Although  the highest  tilers of anti-Sm antibodies were 
encountered among the  lpr/lpr animals, the differences in the peak titers among the 
responding animals of both strains did not achieve statistical significance (P =  0.08, 
Mann-Whitney U  test). 
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F:o.  1.  Anti-DNA and anti-Sm antibody expression in MRL-lpr/lpr  mice. Serial determinations 
of anti-DNA and anti-Sm antibody levels are presented for three representative MRL-lpr/Ipr mice 
that expressed both anti-DNA and anti-Sin antibodies. Results for anti-Sm antibody are presented 
in terms of the PHA titer using RTE cells, whereas anti-DNA antibody levels are presented in terms 
of the OD417 produced in an ELISA assay. 
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FIo.  2.  Anti-DNA and anti-Sm antibody expression in MRL-+/+  Mice. Determinations of anti- 
DNA and anti-Sm antibody levels were performed on serial bleedings on three of the +/+  animals 
studied that produced significant anti-Sm antibodies. Results are presented as described in Fig.  1. D.  S.  PISETSKY,  G.  A. McCARTY,  AND D.  V.  PETERS  1305 
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F[o.  3.  Comparison of peak anti-Sm antibody responses of MRL mice. The peak anti-Sm antibody 
titers by the PHA assay have been plotted for the individual lpr/lpr and +/+ mice studied. 
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FIo. 4.  Comparison of peak anti-DNA antibody responses of MRL mice. Peak anti-DNA antibody 
levels for individual MRL mice of both substrains are plotted in terms of the OD417 obtained by 
an ELISA assay. 
Anti-DNA Responses in MRL Substrain Mice.  The anti-DNA antibody levels in these 
serial bleedings were  determined  by  an  ELISA assay specific for  anti-native  DNA 
antibodies. For lpr/Ipr  mice, a very consistent pattern of responsiveness was observed, 
with individual animals producing serum anti-DNA antibody according to a  similar 
time course  (Fig.  1).  Individual +/+  mice, on  the other hand,  displayed uniformly 
low levels of anti-DNA antibodies until as long as a  year of age  (Fig. 2).  In terms of 
the peak antibody levels,  lpr/lpr  responses varied by a  factor of 4, whereas  for the 
+/+  mice, with much  lower responses, the variation for individual animals was less 
than twofold (Fig. 4). Unlike the antibody response to Sm, the peak anti-DNA levels 1306  AUTOANTIBODY PRODUCTION  IN MRL MICE 
of the animals of the two substrains differed in a highly statistically significant fashion 
(P <  0.001,  Fisher exact test). 
Time-Course of the Response of Anti-Sin and Anti-DNA  Antibody.  As demonstrated  in 
Figs.  1 and  2,  anti-DNA  and  anti-Sm  antibody  showed  evidence  of independent 
expression, with each response showing a  distinct  time-course in individual  animals. 
Although  not  shown  in  these  figures,  there  were  lpr/lpr  animals  that  failed  to 
demonstrate  anti-Sm  antibodies  over  the  time  period  studied;  the  kinetics  and 
magnitude of the anti-DNA response of these animals did not differ from other  lpr/ 
lpr mice. 
Discussion 
The  results  presented  here  suggest  the  existence  of distinct  immunoregulatory 
disturbances involved in the expression of anti-DNA and anti-Sm antibodies. These 
two  autoantibody  systems  have  both  been  considered  highly  specific  markers  of 
human SLE, and their production  by MRL animals has been cited as evidence for 
the existence of common pathogenetic  mechanisms for murine and human disease. 
Nevertheless, by a variety of criteria, these two autoantibodies appear to be separately 
controlled. Thus, lpr/lpr and +/+  mice showed comparable anti-Sm responses while 
demonstrating significantly different anti-DNA responses. In lpr/lpr animals, where 
both antibodies were found, anti-Sin and anti-DNA demonstrated different kinetics, 
substantiating further their independent  expression. 
Anti-DNA and anti-Sm antibodies also differed in their quantitative production by 
individual animals, Whereas serum anti-DNA antibody varied over less than an order 
of magnitude in individual animals of both substrains, anti-Sm antibody levels varied 
enormously.  Comparison  in  levels  of autoantibody  necessarily  involves certain  as- 
sumptions.  Because autoantibodies  can  participate  in  immune complex  formation, 
becoming unmeasurable when bound in serum or deposited in the tissues, serum levels 
may not  accurately reflect  production.  Analysis of anti-Sm antibody production  at 
the  cellular  level,  however,  would  resolve  ambiguities  relating  to  measurement  of 
antibodies hidden by immune complex formation, and is being initiated. The second 
assumption  concerns  comparison  between  strains  of animals  that  develop  disease 
according  to  different  time-courses.  MRL-lpr/lpr  succumb  to  fatal  autoimmune 
disease  by  6-8  mo,  whereas  MRL-+/+  live  as  long  as  two  years.  It  is  possible, 
therefore, that at an older age +/+  animals would in fact produce as much anti-DNA 
antibody as did the lpr/lpr animals, and older +/+  animals are now being analyzed 
to investigate this  possibility. The occurrence of late anti-DNA production  in  +/+ 
animals would suggest that the action of the  lpr gene is more accurately defined in 
terms  of  its  effect  on  the  time-course  of  anti-DNA  production  rather  than  its 
magnitude,  as these studies would suggest.  Whatever the precise mechanism of lpr 
gene  action,  these  experiments  demonstrate  it  influences  anti-DNA  much  more 
profoundly than the anti-Sm response. 
What are the mechanisms allowing different autoantibodies  to be produced?  For 
the anti-DNA response, the production  of these antibodies  appears to be related to 
polyclonal B cell activation with a time-course similar to the increase in spontaneous 
Ig-producing cells in the MRL-lpr/lpr  mice (15,  30-32).  This temporal increase in 
splenic Ig-producing cells has been considered a  reflection of an abnormal state of B 
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anti-DNA  antibodies,  an  abnormal  state of B  cell  activity may be a  predominant 
mechanism  for  the  production  of these  antibodies.  The  correlation  of anti-DNA 
production with generalized B cell hyperactivity is further substantiated by the failure 
of MRL-+/+  mice  to  produce  significant  quantities  of anti-DNA  antibody  when 
their level of spontaneous  B  cell  activation  is comparable with  many normal mice 
strains. 
For anti-Sm antibody, it is not possible to correlate its expression with evidence of 
B cell activation. Thus,  lpr/lpr animals with B cell hyperactivity frequently fail to 
express anti-Sm antibodies,  whereas  +/4-  mice with  apparently normal  levels of B 
cell  activation  produce  anti-Sm  antibodies  to  a  similar extent  as  lpr/lpr  animals. 
This result may suggest that B cells producing anti-Sm antibodies belong to a subset 
whose  activity  is  not  mirrored  by  spontaneous  Ig  production  and  is  presumably 
different from the subset of cells producing anti-DNA antibody. Whereas the activa- 
tion  of this population  may be responsible for anti-Sm production,  these cells may 
represent a minority population and may therefore be difficult to detect. Alternatively, 
anti-Sm production may differ entirely from that of anti-DNA and may not require 
an abnormal population of B cells. Rather, immunoregulatory defects consequent to 
disturbances among T  cells may initiate anti-Sm production. 
Whatever  the  mechanism  responsible  for anti-Sm  production,  it  is  necessary  to 
account for the large variability of this response. This pattern could be explained in 
part by the existence of a limited number of precursors for anti-Sm production. If the 
activation of these precursors (by whatever mechanism) occurred randomly, then the 
distribution  of responses  would  be  expected  to  follow  a  Poisson  distribution;  the 
number  of  animals  that  express  anti-Sm  antibody  would  be  determined  by  the 
number of responding units or precursors present in each animal. A limiting number 
of such precursors in contrast to a much larger number for anti-DNA precursors could 
account  for  highly  variable  anti-Sm  levels  in  face  of  more  consistent  anti-DNA 
responses. The number of precursors for these two antibodies may in turn reflect the 
number of distinct  specificities for anti-DNA and anti-Sm responses in the antibody 
repertoire.  From hybridoma antibody studies,  it is now known  that  for MRL  mice 
there exist at  least several distinct  types of anti-DNA antibodies of unique  binding 
specificity (33). With diversity among anti-DNA antibodies, there exists the potential 
for a large B cell population committed to this type of autoantibody production. The 
activation of even a  limited number or subset of such precursor cells would result in 
anti-DNA antibody in every animal of the strain. The existence of germ line genes for 
anti-DNA antibodies would assure representation of such specificities in the repertoire 
(and  B  cell  precursor  population),  and  provide  a  mechanism  for  their  invariant 
expression when B cells are activated.  In contrast,  the repertoire of unique  anti-Sm 
specificities in  MRL  mice may be very limited,  relating perhaps to the  paucity or 
absence  of  germ  line  genes  for  such  antibodies.  Without  genetically  determined 
specificities, somatic mutation would be required for the generation of a repertoire of 
anti-Sm  antibodies.  The  magnitude  of the  response  of individual  animals  would 
therefore reflect the total number of appropriate precursors generated by mutational 
events,  with  the  variation  among  individual  animals  demonstrating  the  random 
quality  of this  process.  If such  mutational  events  occurred  at  various  time  points 
throughout  the  life  of an  animal,  the  highly  variable  time course  of the  anti-Sm 
response would be explained.  It is hoped that  the study of autoantibodies  from the 1308  AUTOANTIBODY  PRODUCTION IN MRL MICE 
perspective  of  idiotype  will  define  more  fully  the  contribution 
mechanisms for the generation of autoantibodies. 
of  these  various 
Summary 
The quantitative  expression  of anti-DNA and anti-Sm  antibodies  has been inves- 
tigated in autoimmune MRL- lpr/lpr and MRL-+/+  mice. Anti-Sm antibodies were 
detected  in sera from 21/23  lpr/lpr  and  10/16 +/+  mice, with  individual  animals 
showing striking  variation  in  the  time-course  and  magnitude  of this  autoantibody 
response.  The peak antibody levels of the responding animals of each substrain  did 
not differ significantly. For anti-DNA antibody, a  different pattern  of responsiveness 
was observed.  Individual  animals of each substrain  produced  very similar responses 
in  terms  of  the  magnitude  and  time-course  of serum  anti-DNA  antibody.  The 
differences in the peak levels of the two substrains were highly significant, with  lpr/ 
lpr mice demonstrating a much greater anti-DNA antibody response than +/+  mice. 
In 1 pr/lpr  mice tested for both autoantibody systems, serum anti-DNA and anti-Sm 
antibodies  showed  distinct  time-courses.  These  studies  indicate  that  anti-DNA  and 
anti-Sm antibodies are expressed independently in MRL mice, with the expression of 
anti-DNA, but not anti-Sm antibody markedly influenced by the presence of the  lpr 
gene. A fundamental difference in the mechanisms involved in the generation ofanti- 
DNA  and  anti-Sm  antibodies  is  suggested  by the  quantitative  pattern  of the  two 
responses. 
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